Sign in

Pascalis Vergidis, MD

@pascalisid.bsky.social
986 followers 1.7K following 39 posts

Infectious Disease physician | Professor at Mayo Clinic | Microbiology Course Director | ABIM Governance Member

PostsRepliesMedia
Pascalis Vergidis, MD @pascalisid.bsky.social · 19/04/2026
Bismarck Bisono presenting @escmid.bsky.social on invasive aspergillosis in patients with chronic lymphocytic leukemia
020
Pascalis Vergidis, MD @pascalisid.bsky.social · 15/04/2026
Y ou know about invasive aspergillosis in AML. Do you want to learn what happens in Chronic Lymphocytic Leukemia? Dr. Bismarck Bisono will discuss risk factors and outcomes. First presentation in IFI session @escmid.bsky.social
020
Pascalis Vergidis, MD @pascalisid.bsky.social · 28/03/2026
Mary Bowden, MD was fired by her own institution for prescribing ivermectin to treat Covid-19 (among other reasons). She has recently drawn attention for targeting doctors starting their training. We (as medical community) are not obligated to engage with or amplify her posts.
000
Pascalis Vergidis, MD @pascalisid.bsky.social · 25/03/2026
Long term Mpox sequelae www.acpjournals.org/doi/10.7326/...
acpjournals.org
Summary for Patients: Long-Term Mpox Sequelae 11 to 18 Months After Acute Illness | Annals of Internal Medicine
000
Pascalis Vergidis, MD @pascalisid.bsky.social · 25/03/2026
Serofast in syphilis refers to a state where patients have persistently reactive nontreponemal test titers despite successful treatment, without evidence of treatment failure or reinfection.
010
Pascalis Vergidis, MD @pascalisid.bsky.social · 24/01/2026
Department of Medicine Staff Awards @mayocliniccancer.bsky.social Honored to be a Member of the amazing CAR-T cell therapy team.
000
Pascalis Vergidis, MD @pascalisid.bsky.social · 23/01/2026
Mycology Lab for the medical students at Mayo Clinic Alix School of Medicine. We reviewed morphological differences between Aspergillus and Mucorales.
140
Pascalis Vergidis, MD @pascalisid.bsky.social · 22/01/2026
Included in this year’s Mycology Lecture for the medical students at Mayo Clinic Alix School of Medicine. Trichophyton indotinae, an emerging fungal threat
000
Pascalis Vergidis, MD @pascalisid.bsky.social · 17/01/2026
Microbiology course at Mayo Clinic Alix School of Medicine. We reviewed 4 case of tuberculosis with a focus on social determinants of health. Excellent discussion led by our social worker, Mariah Thompson, and Dr. Zami Temesgen, principal investigator Mayo Clinic Center for Tuberculosis.
230
Pascalis Vergidis, MD @pascalisid.bsky.social · 14/01/2026
Bacteriology Lab for the medical students at Mayo Clinic Alix School of Medicine led by Dr. Bobbi Pritt. We had 12 stations. All about Gram stains and cultures! Note the green metallic sheen of E. coli on Eosin Methylene Blue (EMB) agar.
120
Pascalis Vergidis, MD @pascalisid.bsky.social · 12/01/2026
Introduction to Microbiology for the medical students at the Mayo Clinic Alix School of Medicine We discussed this MMWR publication which brought us back to the onset of the #HIV epidemic.
140
Pascalis Vergidis, MD @pascalisid.bsky.social · 06/12/2025
Looking forward to our journal club #MayoClinic Infectious Disease Fellowship. Adjunctive corticosteroids in hypoxemic patients with non-HIV Pneumocystis pneumonia. No difference in 28-day mortality. However, need for mechanical ventilation was lower in the steroid group.
250
Pascalis Vergidis, MD @pascalisid.bsky.social · 05/12/2025
As a member of the ABIM Infectious Disease Approval Committee, I would like to congratulate those who recently passed their Boards. You are all committed to delivering exceptional patient care and upholding the highest standards in Medicine.
130
Reposted by Pascalis Vergidis, MD
Joanna Schaenman, MD, PhD @jschaenmanmd.bsky.social · 20/10/2025
How best to treat invasive aspergillosis? @pascalisid.bsky.social reviewing key clinical studies informing this choice - important to monitor vori levels , NB: AmB <vori=isavu @idweek.bsky.social #IDWeek2025 #TxID #IDSky
151
Pascalis Vergidis, MD @pascalisid.bsky.social · 18/10/2025
Please join us this Monday 8-9 am at IDWeek. Difficult-to-treat mold infections. Dimitrios Farmakiotis will be discussing treatment of mucormycosis. I will be discussing aspergillosis.
3102
Reposted by Pascalis Vergidis, MD
University of Minnesota Infectious Diseases @umn-idim.bsky.social · 07/10/2025
There’s now an app for all things fungi 🦠🍄 Dr. Matthew Pullen, Assistant Professor at the University of Minnesota, helped launch Dr Fungus—a free app that brings the trusted resource to your phone. Explore fungal infections, antifungal treatments, and case-based learning—all in one place.
drfungus.org
Home - Doctor Fungus
Welcome to Doctor Fungus! An Educational Website of theMycoses Study Group Education and Research Consortium (MSGERC)   [View Legal Information] Where to Start Mycology Case of the Month An Introducti...
24316
Reposted by Pascalis Vergidis, MD
Alex Sundermann, DrPH @sundermannaj.bsky.social · 10/07/2025
🆕 MMWR: In NYC, NDM-CRE just surpassed KPC-CRE for the first time. And nearly 75% of these cases had no long-term care facility link This is a changing landscape of antibiotic resistance - happening across US #IDSky 📄: www.cdc.gov/mmwr/volumes...
383
Reposted by Pascalis Vergidis, MD
Ilan Schwartz @germhuntermd.bsky.social · 20/06/2025
Detection of Mucorales antigen in BAL samples using a newly developed lateral-flow device A Mucorales antigen test is sorely needed This one had Sn of 76.92%, Sp of 75.51%, respectively, PPV 45.45%, and a NPV 92.5% (Not good enough but could augment qPCR) journals.asm.org/doi/10.1128/...
Lateral flow device showing positive control (line at C but not T), negative control (line at both C and T), and a test sample (lines at both C and T shown). The test line (T) disappears when the antigen is present. ROC for the lateral flow device for mucorales antigen TG-11. The AUC is 0.739
2228
Pascalis Vergidis, MD @pascalisid.bsky.social · 13/06/2025
Join us for a panel discussion on “Leveraging Partnerships to Fight Fungal Diseases” June 19 2.55-3.25 pm @ASMicrobiology Dallas Smith @CDCgov Sean Zhang, Fungal Diagnostics Laboratory Consortium Rob Purdie, MYCology Advocacy, Research & Education Zachary Rubin @lapublichealth Me @MSG_ERC
251
Pascalis Vergidis, MD @pascalisid.bsky.social · 12/06/2025
Visited the historic city of Philadelphia to attend the American Board of Internal Medicine (ABIM) New Governance Orientation. Looking forward to serving on the Infectious Disease Approval Committee. Of the profession, for the public
130
Pascalis Vergidis, MD @pascalisid.bsky.social · 08/06/2025
Synthesis of the available literature on the use of CMV-specific T-cell therapy in adult and pediatric HSCT and SOT recipients. Several patients on concurrent antivirals, which confounded the effectiveness of VSTs @CIDJournal @transplantidnet.bsky.social academic.oup.com/cid/advance-...
academic.oup.com
Virus-Specific T-Cell Therapy for Prophylaxis and Treatment of Cytomegalovirus Infections After Transplantation: a Scoping Review
Cytomegalovirus-specific T cells have been used in studies of primarily adult hematopoietic stem cell transplant recipients. Heterogenous trial design and
050
Pascalis Vergidis, MD @pascalisid.bsky.social · 06/06/2025
Dr. Jeniel Nett discussing biofilm at the 2025 Scientific Meeting on Candida auris @msgerc.bsky.social
020
Pascalis Vergidis, MD @pascalisid.bsky.social · 06/06/2025
High Kaposi sarcoma-associated herpesvirus seroprevalence in donors and recipients with HIV, particularly among MSM. Reassuringly, disease was rare. @transplantidnet.bsky.social academic.oup.com/cid/advance-...
academic.oup.com
Kaposi Sarcoma–Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With Human Immunodeficiency Virus in the United States
The prevalence of Kaposi sarcoma–associated herpesvirus (KSHV) was high among kidney donor and transplant recipients with HIV. Posttransplant KSHV-associat
020
Pascalis Vergidis, MD @pascalisid.bsky.social · 02/06/2025
In a phase 3 clinical trial, pemivibart provided prophylactic efficacy against COVID-19 in immunocompromised patients and individuals at risk for exposure. Four of 623 participants experienced anaphylactic reactions @transplantidnet.bsky.social academic.oup.com/cid/advance-...
academic.oup.com
Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)
AbstractBackground. We report an interim analysis of safety and efficacy of pemivibart in individuals with (cohort A) or without (cohort B) significant imm
030
Reposted by Pascalis Vergidis, MD
Ilan Schwartz @germhuntermd.bsky.social · 15/05/2025
Increasing Fluconazole Resistance in Candida parapsilosis: A 10-Year Analysis of Blood Culture Isolates at a US Reference Laboratory (2015–2024) Fluco-R C parapsilosis ⬆️ from 8.2% to 20.3% in BCx isolates tested @ Mayo Jack McHugh ... @pascalisid.bsky.social academic.oup.com/jid/advance-...
Line graph showing year-to-year fluctuation but general increase in fluconazole resistance (lowest was 6% in 2018, highest was 21% in 2024), with slight increase in voriconazole and posaconazole resistance (up to 5% in 2024), and micafungin resistance that briefly reached 5% in 2023 before dropping again
062
Reposted by Pascalis Vergidis, MD
Ilan Schwartz @germhuntermd.bsky.social · 31/03/2025
This #TransDayofVisibility 🏳️‍⚧️ Please know: We see you, & we will continue to fight for you.
0103
Pascalis Vergidis, MD @pascalisid.bsky.social · 23/03/2025
ID Grand Rounds. I discussed the following: - ONE Health - Aspergillus urine antigen - Giant magnetoresistance-enabled PCR - Rezafungin for prevention in bone marrow transplant - Ibrexafungerp (FURI) - Olorofim (Study 32) - Our experience with fosmanogepix
060
Pascalis Vergidis, MD @pascalisid.bsky.social · 13/03/2025
In rare cases, vaping-associated lung injury (EVALI) may lead to irreversible damage requiring lung transplantation
010
Pascalis Vergidis, MD @pascalisid.bsky.social · 12/03/2025
Can filgrastim precipitate organ rejection ?
000
Pascalis Vergidis, MD @pascalisid.bsky.social · 27/02/2025
We used Giant Magnetoresistance to diagnose invasive fungal infection. The assay has the potential to detect trace amounts of fungal DNA in serum academic.oup.com/ofid/article...
academic.oup.com
A Novel Giant Magnetoresistance–Enabled Multiplex Polymerase Chain Reaction Assay for the Diagnosis of Invasive Fungal Infection
AbstractBackground. Despite advances in clinical microbiology, the diagnosis of invasive fungal infections remains challenging. Giant magnetoresistance (GM
030
Pascalis Vergidis, MD @pascalisid.bsky.social · 26/02/2025
Aspergillus pseudodeflectus belongs to the Aspergillus section Usti. Can be multidrug resistant (similar to calidoustus) - Learning something every day!
140
Pascalis Vergidis, MD @pascalisid.bsky.social · 22/02/2025
Highly recommended! Fungal Update: Mycology 2025 in London. This a pic from last year… @germhuntermd.bsky.social
1131
Pascalis Vergidis, MD @pascalisid.bsky.social · 21/02/2025
Recommendation to screen, even though no cases of TB transmission reported after allogeneic stem cell transplant
fda.gov
Recommendations to Reduce the Risk of Transmission of Mtb
This is the Guidance for Industry - Recommendations to Reduce the Risk of Transmission of Mycobacterium tuberculosis (Mtb) by Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps)
000
Pascalis Vergidis, MD @pascalisid.bsky.social · 20/02/2025
Remember that fosmanogepix can cause neurotoxicity (approx 10%)
170
Pascalis Vergidis, MD @pascalisid.bsky.social · 19/02/2025
Generative AI platforms for clinical conversations create mediocre medical notes
020
Reposted by Pascalis Vergidis, MD
Pascalis Vergidis, MD @pascalisid.bsky.social · 16/02/2025
Mayo Clinic remains committed to Diversity and Inclusion
mayoclinic.org
Equity, Inclusion and Diversity at Mayo Clinic
To provide the best care experience, Equity, Inclusion and Diversity at Mayo Clinic provides a variety of services to meet the diverse needs of patients.
2193
Pascalis Vergidis, MD @pascalisid.bsky.social · 17/02/2025
You are all familiar with immune checkpoint inhibitor-associated pneumonitis. Adagrasib inhibits KRAS G12C and is used to treat non-small cell lung cancer. It can also be associated with pneumonitis. Need to rule out infection first. Discontinue adagrasib and treat with corticosteroids.
020
Pascalis Vergidis, MD @pascalisid.bsky.social · 16/02/2025
Mayo Clinic remains committed to Diversity and Inclusion
mayoclinic.org
Equity, Inclusion and Diversity at Mayo Clinic
To provide the best care experience, Equity, Inclusion and Diversity at Mayo Clinic provides a variety of services to meet the diverse needs of patients.
2193
Reposted by Pascalis Vergidis, MD
Pascalis Vergidis, MD @pascalisid.bsky.social · 09/02/2025
We had a great conference. Looking forward to Mayo Clinic Infectious Disease Updates 2026 in Maui!
091
Pascalis Vergidis, MD @pascalisid.bsky.social · 09/02/2025
We had a great conference. Looking forward to Mayo Clinic Infectious Disease Updates 2026 in Maui!
091
Reposted by Pascalis Vergidis, MD
Pascalis Vergidis, MD @pascalisid.bsky.social · 08/02/2025
Mayo Clinic CME Infectious Disease Updates. Successful session on Infections in Hematology. We discussed advances in the diagnosis and treatment of fungal infection, duration of treatment for febrile neutropenia, complications of CAR-T cell therapy, fusariosis and breakthrough aspergillosis.
081
Pascalis Vergidis, MD @pascalisid.bsky.social · 08/02/2025
Mayo Clinic CME Infectious Disease Updates. Successful session on Infections in Hematology. We discussed advances in the diagnosis and treatment of fungal infection, duration of treatment for febrile neutropenia, complications of CAR-T cell therapy, fusariosis and breakthrough aspergillosis.
081
Reposted by Pascalis Vergidis, MD
Luis Ostrosky, MD, FIDSA @drluiso.bsky.social · 23/12/2024
Coming soon to a city near you… bonus points if you can name the soon to be un-eradicated vaccine-preventable diseases. #IDSky
4185
Pascalis Vergidis, MD @pascalisid.bsky.social · 08/12/2024
Aspergillus ustus tracheobronchitis. Necrotic debris within the airways. One month post-transplant for ILD. Breakthrough on posaconazole prophylaxis (level 832 ng/mL). Susceptibilities are pending. How would you treat?
2366
Pascalis Vergidis, MD @pascalisid.bsky.social · 08/12/2024
Aspergillus was named by Pier Antonio Micheli, an Italian priest and biologist. The molds resembled an aspergillum, a holy water sprinkler.
111117